Synthetic heparin touted at ACS meeting
A research team may have produced a more pure and safer alternative to heparin.
A research team may have produced a more pure and safer alternative to heparin by building the first fully synthetic heparin. Its creation, featured at the national conference of the American Chemical Society, is the largest dose of heparin ever created in the lab.
"Unlike the current heparin that is harvested from possibly disease carrying animals in often very poor conditions, our fully synthetic heparin will be created in a pharmaceutical manufacturing environment from fermentation to packaging," Rober Linhardt told Newswise. "This will give drug manufacturers extreme control over the safety and purity of the product."
For the complete story, click here.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
